You are here

apraglutide

Ironwood spies new frontier for $1B GLP-2 analog in exploratory phase 2 rare disease trial

Fierce Biotech

Thu, 03/28/24 - 11:16 am

Ironwood Pharmaceuticals

graft vs host disease

Pipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpoints

Clinical Trials Arena

Mon, 03/18/24 - 11:09 am

Ironwood Pharmaceuticals

short bowel syndrome

clinical trials

Ironwood's bowel disease treatment meets main goal in late-stage trial

Reuters

Thu, 02/29/24 - 11:02 am

chronic intestinal failure

clinical trials

short bowel syndrome